Neudle.com: patient selection

Differential
(Click to cross reference)

acquired immunodeficiency syndrome

advances in neurology

adverse drug reaction

albendazole

Alberta Stroke Program Early CT score

algorithm

alpha-fetoprotein

amniocentesis

amygdalohippocampectomy

anatomy of

anterior cerebral artery, occlusion of

anterior temporal branch of posterior cerebral artery

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, compliance

anticonvulsants, discontinuation

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, generic

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

aphasia

apixaban

arterial dissection

artificial intelligence

calcification, intracranial

carotid artery occlusion, intracranial

CAT scan

CAT scan, abnormal

CAT scan, angiography

CAT scan, attenuation coefficient

CAT scan, dense artery sign

CAT scan, early changes in CVA

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, indications for

CAT scan, mismatch between cerebral blood volume/flow

CAT scan, mismatch between perfusion/diffusion

CAT scan, net water uptake

CAT scan, perfusion

cerebral embolism

cerebral embolism, cardiac origin

cerebral embolism, mechanical extraction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, age of lesion

cerebrovascular accident, anticoagulant treatment

cerebrovascular accident, awakening with

cerebrovascular accident, bilateral

cerebrovascular accident, complications with

cerebrovascular accident, cryptogenic

cerebrovascular accident, delay in treatment

cerebrovascular accident, large

cerebrovascular accident, large ischemic core

cerebrovascular accident, mimics

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, secondary prevention

cerebrovascular accident, seizure with

cerebrovascular accident, severity

cerebrovascular accident, silent

cerebrovascular accident, surgical treatment of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of onset

cerebrovascular accident, time of presentation

cerebrovascular accident, time to treatment

cerebrovascular accident, unknown time of onset

cerebrovascular accident, volume

cerebrovascular accident, work up for

cerebrovascular accident, young adult

children

clinical mismatch

Clinical Pathologic Conference(C.P.C.)

clot retrieval

cognition

collateral circulation

compliance

complications

computers, handheld

computers, medicine and

computers, neurologic diagnosis and

congenital birth defects

congenital malformation

contraindications

controversies in neurology

cortical infarction, small

cost

cost effectiveness

counselling

craniectomy, decompressive

C-reactive protein

C-reactive protein, elevated

cysticercosis

cysticercosis, cerebral

dementia, diagnostic evaluation of

dense middle cerebral artery sign

dense posterior cerebral artery sign

deprescribing

dermatomyositis

developmental retardation

diagnosis related group

diet

disability rating scale, neurological

disability, neurological

doppler

doppler, transcranial

driving

drug abuse, toxic screen In

drug interactions

drug of choice

echocardiogram

echocardiogram, transesophageal

efficacy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, monitoring, continuous

electroencephalogram, pediatric patients

electroencephalogram, video monitoring with

ELISA

embolism, paradoxical

endovascular therapy, futile interhospital transfer

endovascular therapy, late time window

endovascular therapy, selection criteria

endovascular therapy, time window

ENRICH trial

enzyme, induction

epidemiology of neurology

epilepsy

epilepsy referral centers

epileptologist

ethics in neurology

evidence-based research

factor Xa inhibitor

felbamate

fibrinolytic agents

fibrinolytic agents, combined IA and IV

fibrinolytic agents, complications

fibrinolytic agents, contraindications

fibrinolytic agents, exclusion criteria

fibrinolytic agents, intra-arterial local infusion

fibrinolytic agents, utilization

fibrinolytic therapy, selection criteria

fibrinolytic therapy, timing of administration

folic acid

gabapentin

gammaglobulin therapy, intravenous

gastrointestinal bleeding

generic drugs

genetic counselling

Gilles de la Tourette syndrome

Gilles de la Tourette syndrome, deep brain stimulation

Gilles de la Tourette syndrome, deep brain stimulation, selection criteria

glucose level, serum

GOLIATH trial

Guatemala

Guillain Barre syndrome

head injury

hemianopia

hemianopia, homonymous

hemiparesis

hemiplegia

hemoglobin A1c

hippocampal infarction

human immunodeficiency virus type 1

idarucizumab

inclusion body myositis

Index medicus

infection

informed consent

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, lobar

intracerebral hemorrhage, location of

intracerebral hemorrhage, treatment of

intracerebral hemorrhage, volume

Lennox-Gastaut syndrome

levonorgestrel

lumbar puncture

lumbar puncture, indications for

malpractice

medical-legal aspects of neurology

memory, impairment of

menses

menses, seizure with

mental status, abnormal

MERCI trial

microhemorrhage, intracerebral

middle cerebral artery

middle cerebral artery, occlusion of

mimics

minimally invasive surgery

MRI, angiography, contrast enhanced

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, diffusion weighted

MRI, early changes in CVA

MRI, gradient-echo

MRI, indications for

MRI, mismatch between DWI/FLAIR

MRI, mismatch between perfusion/diffusion

MRI, ring sign

multimodal neuroimaging

multiple subpial transection

myasthenia gravis

myasthenia gravis, treatment of

neoplasm, intracranial-incidence and epidemiology of

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination, fluctuating

neurologic examination, focal

neuropathy, motor, multifocal

neuroradiology, interventional

NIH stroke scale

NIH stroke scale, fluctuating

non-vitamin K antagonist oral anticoagulants

number needed to treat

obstetric neurologic injuries

occipital lobe, infarction

old age, neurology of

oral contraceptives

outcome research

oxcarbazepine

parietal lobe, lesion of

Parkinson disease

Parkinson disease, treatment of

patent foramen ovale

patent foramen ovale, surgical treatment of

patient information and support

patient selection

patient-oriented outcomes

perampanel

physician as patient

platelet count

platelet inhibiting drugs

polymyositis

polyneuropathy, chronic inflammatory demyelinating

polypharmacy

posterior cerebral artery

posterior cerebral artery embolism

posterior cerebral artery territory infarction

posterior cerebral artery, fetal type

posterior fossa, lesion of

practice guidelines

precipitating factors

pregabalin

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

prenatal diagnosis by amniocentesis

prevention of neurologic disorders

prognosis

protocol violations

psychiatric problems in neurologic disorders

RAPID CT perfusion maps

recanalization, arterial

referral, neurologic

reperfusion

Retriever Device

revascularization, surgical

review article

risk factors

risk-benefit assessment

seizure, age of onset

seizure, breakthrough

seizure, children

seizure, classification of

seizure, complications following

seizure, diagnosis of

seizure, differential diagnosis of

seizure, driving with

seizure, drug resistance

seizure, EEG normal during

seizure, EEG pattern in

seizure, employment with

seizure, intractable, treatment of

seizure, medication failure

seizure, neonatal

seizure, new onset

seizure, precipitating factors

seizure, pregnancy

seizure, prevention of

seizure, prognosis in adults

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, recurrent

seizure, restrictions following

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment, adjunctive therapy

steroid therapy, CNS treatment and complications with

stillbirth

stimulation, deep brain

stroke center

stroke disability scale

stroke protocol

stroke, progression of

symptomatic

temporal lobectomy

teratogenesis

thalamus, infarction of

thrombectomy

thrombocytopenia

thrombolysis, mechanical

thrombus, atrial

time is brain

tissue plasminogen activator, intravenous

topiramate

transport of patient

trauma

treatment of neurologic disorder

Trevo retriever

ultrasonography

urine test in toxic screen

vagus nerve stimulation

vitamin supplementation

WAKE-UP trial

workers' compensation

workup

Showing articles 50 to 100 of 1742 << Previous Next >>

Safety of Thrombolysis in Patients Over the Age of 80
The Neuroogist 18:99-101, Willey,J.Z.,et al, 2012

Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012

Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score
Ann Neurol 71:634-641, Strbian,D.,et al, 2012

Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008

Thrombolysis in Patients With Marked Clinical Fluctuations in Neurologic Status Due to Cerebral Ischemia
Arch Neurol 65:1041-1043,1017, Ozdemir,O.,et al., 2008

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008

A 24-Year-Old Woman with Intractable Seizures: Review of Surgery for Epilepsy
JAMA 300:2527-2538,2568, Schomer,D.I. &Black,P.M., 2008

Neuroimaging in Acute Posterior Cerebral Artery Infarction
The Neurologist 14:170-180, Finelli,P.F., 2008

Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke 38:2612-2618, De Keyser,J.,et al, 2007

Practice Parameter: Evaluating an Apparent Unprovoked First Seizure in Adults (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
Neurol 69:1996-2007, Krumholz,A.,et al, 2007

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke 38:7579, Dzialowski,I.,et al, 2007

Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007

Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007

Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007

Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006

The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006

Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke 37:2963-2969, Kent,D.M.,et al, 2006

Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006

The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006

Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006

Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006

Adult Epilepsy
Lancet 367:1087-1100, Duncan,J.S.,et al, 2006

Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Status Epilepticus: An Evidence Based Guide
BMJ 331:673-677, Walker,M., 2005

Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004

Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004

Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004

Epilepsy
JAMA 291:654, Parmet,S, 2004

Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003

A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003

Practice Parameter: Temporal Lobe and Localized Neocortical Resections for Epilepsy
Neurol 60:538-547, Engel,J.,et al, 2003

Getting Oriented to Patient-Oriented Outcomes
Neurol 53:662-663, Vickrey,B.G., 1999

Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Showing articles 50 to 100 of 1742 << Previous Next >>